Neutropenia and fever in the patient with cancer;Neutropenia y fiebre en el paciente con cáncer

Anales del Sistema Sanitario de Navarra

Volumn 27, Issue SUPPL. 3, 2004, Pages 33-43

  Manterola, Ana ^a   Romero, P ^a   Martinez E ^a   Villafranca, E ^a   Arias, F ^a   Dominguez M A ^a   Martinez M ^a  

^a Instituto de Investigación Sanitaria de Navarra   (Spain)

Author keywords

Antibiotics; Cancer; Fever

Indexed keywords

AMIKACIN; AMOXICILLIN PLUS CLAVULANIC ACID; AMPHOTERICIN B; AMPHOTERICIN B LIPID COMPLEX; ANTIBIOTIC AGENT; ANTIFUNGAL AGENT; ANTINEOPLASTIC AGENT; AZTREONAM; CARBOPLATIN; CARMUSTINE; CEFEPIME; CEFTAZIDIME; CIPROFLOXACIN; CISPLATIN; DOCETAXEL; DOXORUBICIN; FLUCONAZOLE; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; IFOSFAMIDE; IMIPENEM; IRINOTECAN; LEVOFLOXACIN; MEROPENEM; METHOTREXATE; PIPERACILLIN; TOPOTECAN; VANCOMYCIN;

ADENOVIRUS; ANAEROBIC BACTERIUM; ANAMNESIS; ASPERGILLUS; BLOOD CELL COUNT; BLOOD CHEMISTRY; BLOOD CULTURE; CANCER; CANDIDA; COMPUTER ASSISTED TOMOGRAPHY; FEBRILE NEUTROPENIA; FUSARIUM; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE COCCI; HERPES VIRUS; HIGH RISK PATIENT; HUMAN; INFECTION; INFLUENZA VIRUS; LUMBAR PUNCTURE; MONOTHERAPY; PARAINFLUENZA VIRUS; PHYSICAL EXAMINATION; PRACTICE GUIDELINE; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; REVIEW; RHINOVIRUS; RHIZOPUS; SYSTEMATIC REVIEW; THORAX RADIOGRAPHY; TRICHOSPORON; URINE CULTURE;

CLINICAL PROTOCOLS; FEVER; HUMANS; INFECTION; NEOPLASMS; NEUTROPENIA;

EID: 14744287152     PISSN: 11376627     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (20)

1. BODEY GP, BUCLEY M, SATHE YS, FREIREICH EJ. Quantitative relationships between circulating leukocytes and infection in patients with acute leukemia. Ann Inter Med 1966; 64: 328-340.
2. PIZZO PA. Management of fever in patients with cancer and treatment-induced neutropenia. N Engl J Med 1993; 328: 1323-1332.
3. SANCHEZ-MUÑOZ A, GARCÍA-CARBONERO R, CORTÉS-FUNES H, PAZ-ARES L. Envolving treatment of fever and neutropenia in cancer patients. Rev Oncol 2002; 4: 297-307.
4. 2002 Guidelines for the use of Antimicrobial Agents in Neutropenic Patients with Cancer. Hughes W.T, Armstrong D, Bodey G.P, Bow E.J, Brown A.E, Calandra T et al. Clin Infect Dis 2002; 34: 730-751.
5. a Edition. Chap. 54: Infections in the Cancer Patient.
6. PIZZO PA. Fever in inmunocompromised patients. N Engl J Med 1999; 341: 893-900.
7. TALCOTT JA, SIEGEL RD, FINBERG R, GOLDMAN L. Risk assesment in cancer patients with fever and neutropenia: a prospective, two center validation of a prediction rule. J Clin Oncol 1992; 10: 316-322.
8. QUADRI TL, BROWN AE. Infectious complications in the critically ill patient with cancer. Semin Oncol 2000; 27: 335-346.
9. KLATERSKY J, PAESMANS M, RUBESTEIN EB, BOYER M, ELTING L, FELD R. The Multinational Association for Supportive Care in Cancer Risk Index: A Multinational Scoring System for Identifying Low-Risk Febrile Neutropenic Cancer Patients. J Clin Oncol 2000; 18: 3038-3051.
10. FERNANDEZ ML, TOMÁS JF, BALLESTEROS M, GONZÁLEZ F, PÉREZ-CECILIA E, PICAZO JJ. Atención al paciente neutropénico. Guía razonada de actuación médica en enfermedades infeciosas. Coordinador Juan J. Picazo. 2003 Scientific Communication Management, S.L.
11. KLATERSKY J. Tratamiento de la sepsis en pacientes neutropénicos. Revisiones en Cancer 1999; 13: 255-261.
12. DE PAUW BE, DERESINSKI SC, FELD R, LANE-ALLMAN EF, DONNELLY P. Ceftazidime compared with piperacillin and tobramycin for the empiric treatment of vever in neutropenic patients with cancer. A multicenter randomiced trial. Ann Intern Med 1994; 120: 834-844.
13. PIZZO PA, HATHORN JW, HIEMENZ J, BROWNE M, COMMERS J, COTTON D et al. A randomized trial comparing ceftazidime alone with combination antibiotic therapy in cancer patients with fever and neutropenia. N Engl J Med 1986; 315: 552-558.
14. SANDERS JW, POWE NR, MOORE RD. Ceftazidime monotherapy for empiric treatment of febrile neutropenic patients: A metaanalysis. J Infect Dis 1991; 164: 907-916.
15. WALSH TJ, TEPPLER H, DONOWITZ GR, MAERTENS JA, BADEN LR, DMOSZYNSKA A et al. Caspofungin versus liposomal amphotericina B for empirical antifungal therapy in patients with persistent fever and neutropenia. N Engl J Med 2004; 351: 1391-1402.
16. KERN W, COMETTA A, DE BOCK R, LANGENAEKEN RN, PAESMANS M, GAYA H. Oral versus intravenous empirical antimicrobial therapy for fever in patients with granulocytopenia who are receiving cancer chemotherapy. N Engl J Med 1999; 341: 312-318.
17. FREIFELD A, MARCHIGIANI D, WALSH T, CHANOCK S, LEWIS L, HIEMENZ S et al. A Double-Blind comparison of empirical oral and intravenous antibiotic therapy for low-Risk febrile patients with neutropenia during cancer chemotherapy. N Engl J Med 1999; 341: 305-311.
18. MALIK IA, KHAN WA, KARIM M, AZIZ Z, KHAN MA. Feasibility of outpatient management of fever in cancer patients with low-risk neutropenia: results of a prospective randomized trial. Am J Med 1995; 98: 224-231.
19. OZER H, ARMITAGE JO, BENETT CHL, CRAWFORD J, DEMETRI GD, PIZZO PA et al. 2000 Update of recomendations for the use of hematopoietic colony-stimulating factors: evidence-based, clinical practice guidelines. J Clin Oncol 2000; 18: 3558-3585.
20. GARCÍA-CARBONERO R, MAYORDOMO JI, TORNAMIRA MV, LOPEZ-BREA M, RUEDA A, GULLEM V et al. Granulocyte colony-stimulating factor in the treatment of high-Risk febrile neutropenia: a multicenter randomized trial. J Nat Cancer Inst 2001; 93: 31-38.